Kennedy Capital Management, Inc. Inotiv, Inc. Transaction History

Kennedy Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.27 - $11.04 $7,772 - $26,242	2,377 Added 6.38%	39,631 $433,000
Q4 2023 Feb 14, 2024	SELL	$1.69 - $3.86 $488 - $1,115	-289 Reduced 0.77%	37,254 $136,000
Q3 2023 Nov 14, 2023	SELL	$3.01 - $7.32 $129,119 - $314,006	-42,897 Reduced 53.33%	37,543 $115,000
Q2 2023 Aug 14, 2023	BUY	$4.08 - $7.22 $127,075 - $224,874	31,146 Added 63.18%	80,440 $383,000
Q1 2023 May 15, 2023	BUY	$4.18 - $8.64 $1,040 - $2,151	249 Added 0.51%	49,294 $213,000
Q4 2022 Feb 14, 2023	BUY	$3.77 - $22.1 $13,198 - $77,372	3,501 Added 7.69%	49,045 $242,000
Q3 2022 Nov 14, 2022	SELL	$9.81 - $26.17 $322,121 - $859,318	-32,836 Reduced 41.89%	45,544 $767,000
Q2 2022 Aug 10, 2022	BUY	$9.56 - $25.91 $749,312 - $2.03 Million	78,380 New	78,380 $752,000

3.78M

1.1K

21.3K

Ticker NOTV
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 25,594,500
Market Cap $113M
Description
Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Kennedy Capital Management, Inc. with notifications on news.